Advertisement
Australia markets closed
  • ALL ORDS

    8,022.70
    +28.50 (+0.36%)
     
  • ASX 200

    7,749.00
    +27.40 (+0.35%)
     
  • AUD/USD

    0.6604
    -0.0017 (-0.25%)
     
  • OIL

    78.33
    -0.93 (-1.17%)
     
  • GOLD

    2,375.20
    +34.90 (+1.49%)
     
  • Bitcoin AUD

    91,701.30
    -2,375.37 (-2.52%)
     
  • CMC Crypto 200

    1,254.02
    -103.99 (-7.66%)
     
  • AUD/EUR

    0.6130
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0974
    +0.0006 (+0.05%)
     
  • NZX 50

    11,755.17
    +8.59 (+0.07%)
     
  • NASDAQ

    18,150.40
    +36.94 (+0.20%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • Dow Jones

    39,487.28
    +99.52 (+0.25%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

Why Tilray Is Trouncing the Market This Week

Why Tilray Is Trouncing the Market This Week

Tilray (NASDAQ: TLRY), the big marijuana operator resulting from the recent merger of the namesake company with the former Aprhia, is a stock on fire this week. The "new" Tilray reported its fourth-quarter fiscal 2021 figures on Wednesday, and they looked awfully sweet. Net revenue rose a sturdy 25% year over year to $142 million (taking into account Aphria's performance as a separate company in the year-ago period).